Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Number of holders
-
150
-
Total 13F shares, excl. options
-
54,672,036
-
Shares change
-
+3,919,897
-
Total reported value, excl. options
-
$262,464,060
-
Value change
-
+$16,481,166
-
Put/Call ratio
-
125%
-
Number of buys
-
67
-
Number of sells
-
-74
-
Price
-
$4.80
Significant Holders of CLOVIS ONCOLOGY INC - COM (CLVSQ) as of Q4 2020
214 filings reported holding CLVSQ - CLOVIS ONCOLOGY INC - COM as of Q4 2020.
CLOVIS ONCOLOGY INC - COM (CLVSQ) has 150 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54,672,036 shares
.
Largest 10 shareholders include STATE STREET CORP (14,535,872 shares), BlackRock Inc. (6,845,807 shares), VANGUARD GROUP INC (6,387,215 shares), Palo Alto Investors LP (4,469,411 shares), ARMISTICE CAPITAL, LLC (2,256,000 shares), CITADEL ADVISORS LLC (1,857,735 shares), Point72 Asset Management, L.P. (1,802,756 shares), GEODE CAPITAL MANAGEMENT, LLC (1,350,865 shares), MORGAN STANLEY (1,094,481 shares), and NORTHERN TRUST CORP (973,476 shares).
This table shows the top 150 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.